More On Bifidobacteria and COVID
Proof C19V is not needed for most Vitamin C and or Ivermectin is usually sufficient
Research has highlighted the potential link between the gut microbiome, specifically bifidobacteria, and COVID-19. Here are some key findings:
Depletion of bifidobacteria in severe COVID-19 cases: Studies have shown that individuals with severe and long-lasting COVID-19 tend to have depleted levels of bifidobacteria in their gut microbiome. This depletion may be a biomarker predictive of severe and prolonged COVID-19.
Role of bifidobacteria in regulating immune response: Bifidobacteria have been found to play a crucial role in regulating the immune response to SARS-CoV-2 infection. They may help modulate the immune system’s response to the virus, potentially reducing the severity of COVID-19.
Impact of COVID-19 vaccines on gut microbiome: Research has also shown that COVID-19 vaccines can affect the gut microbiome, reducing its overall population and biodiversity. This may have implications for the immune system’s response to the virus.
Potential therapeutic applications: The connection between bifidobacteria and COVID-19 has sparked interest in exploring microbiome-based interventions to reduce the severity of the disease. Probiotics containing bifidobacteria have been evaluated in post-COVID-19 patients, showing promise in reducing inflammation and improving symptoms.
Key Quotes
“When you see on a paper that patients that had severe COVID-19 had zero bifidobacteria in their gut, you have to ask the question—because that’s what science is about. Science is about asking questions. You have to ask the question ‘Did COVID-19 kill the bifidobacteria? Or did COVID-19 Enter the gut?’ Because the bifidobacteria was low.” - Sabine Hazan, MD, Founder and CEO of Progenabiome
“The use of probiotics has also been evaluated in post-COVID-19 patients. The mixed probiotic contained Lactobacilli and Bifidobacteria… The administration of a probiotic mix to 19 patients discharged after hospitalization for COVID-19 indicated that serum citrulline levels, IL-6, IL-12RA, and TNF-α were significantly reduced at the end of treatment (week 8) compared to baseline levels.” - The Role of Bifidobacterium in COVID-19: A Systematic Review
Sources
Hazan, S. (2022). Microbiome-Based Hypothesis on Ivermectin’s Mechanism in COVID-19: Ivermectin Feeds Bifidobacteria to Boost Immunity. Front. Microbiol. 13:952321. doi: 10.3389/fmicb.2022.952321
Interaction between gut microbiota and COVID-19 and its vaccines - PMC
The Role of Bifidobacterium in COVID-19: A Systematic Review - PMC
The Path To Shortening Long COVID May Go Through Gut
NOTE
This information is educational and not medical advice. Always consult with your own health professional.